HFM Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$115K Buy
124
+1
+0.8% +$1.01K 0.04% 37
2025
Q4
$132K Buy
123
+19
+18% +$18.2K 0.05% 34
2025
Q3
$79.7K Hold
104
0.03% 39
2025
Q2
$81.2K Buy
104
+5
+5% +$3.88K 0.04% 37
2025
Q1
$81K Buy
+99
New +$82.4K 0.04% 31

Other funds holding LLY

HFM Investment Advisors's LLY Position: Q1 2026 in Review

HFM Investment Advisors increased its Eli Lilly (LLY) stake by 0.81% in Q1 2026, buying an estimated $1.01K and bringing the position to 124 shares worth $115K. The position accounts for 0.04% of the portfolio, ranked #37.

HFM Investment Advisors first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $132K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • HFM Investment Advisors held 124 shares of Eli Lilly worth $115K as of Q1 2026.
  • HFM Investment Advisors bought 1 Eli Lilly share in Q1 2026, an estimated $1.01K.
  • Eli Lilly made up 0.04% of HFM Investment Advisors's portfolio in Q1 2026, its #37 holding.
  • HFM Investment Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • HFM Investment Advisors's Eli Lilly position peaked at $132K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on HFM Investment Advisors's 13F filing for Q1 2026, filed 1 May 2026.